Instead, p53 is an oncongene, frequent in HNSCC (60–80% of cases); unfortunately, only a few studies demonstrated a prognostic significance for p53 overexpression, with an association between this parameter, progression to malignancy, and poor patient outcome. The gene discussed is TP53; the disease is head and neck squamous cell carcinoma.